Abstract
Background
Quality of Life Core Questionnaire of the European Organization for the Research and Treatment of Cancer (EORTC QLQ-C30) is one of the most used quality of life questionnaires in cancer studies. It provides scores for five functional scales, nine symptom scales, and two single items which assess overall health status and quality of life. However, high correlations among QLQ-C30 items suggest a reduced dimensionality for the scale.
Objective
To assess the dimensionality of the EORTC QLQ-C30 using item response theory (IRT) in a training sample and confirmatory factor analysis (CFA) in a test sample.
Methods
We analyzed responses to QLQ-C30 from 1,107 patients with advanced lung cancer who were included in five clinical trials of immunotherapy. We used non-parametric and parametric IRT models (Mokken, and Samejima's graded response) in a random training set (n = 332) for initial assessment of dimensions and item characteristics of the QLQ-C30. Finally, we used CFA in the test set (n = 775) to confirm the measurement domains.
Results
Mokken model showed that QLQ-C30 fits a unidimensional scale, whereas Samejima model showed that most QLQ-C30 items present adequate difficulty and discrimination. All items showed adequate scalability indexes with an overall scalability of 0.47 (medium scale). The QLQ-C30-reduced dimensionality was confirmed by CFA (comparative fit index = 0.98, root mean square error of approximation = 0.055) with all items presenting factorial loadings > 0.40.
Conclusions
The EORTC QLQ-C30 fits a unidimensional latent construct identified with perceived quality of life in advanced lung cancer patients.
Trial registration
RPCEC00000161, RPCEC00000181 and RPCEC00000205
Abbreviations
- EORTC QLQ-C30:
-
Quality of life core questionnaire of the European Organization for the Research and Treatment of Cancer
- IRT:
-
Item response theory
- CFA:
-
Confirmatory factor analysis
- QoL:
-
Quality of life
- NSCLC:
-
Non-small-cell lung cancer
- CECMED:
-
Cuban regulatory agency for drugs
- MHM:
-
Monotone homogeneity model
- DMM:
-
Double monotonicity model
- ICC:
-
Item characteristic curve
- CFI:
-
Comparative fit index
- RMSEA:
-
Root mean square error approximation
- GRM:
-
Graded response model
- LRT:
-
Likelihood ratio test
References
Braun, D. P., Gupta, D., & Staren, E. D. (2011). Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer, 11(1), 353.
Gupta, D., Braun, D. P., & Staren, E. D. (2012). Association between changes in quality of life scores and survival in non-small cell lung cancer patients. European Journal Cancer Care, 21(5), 614–622.
Li, T.-C., Li, C.-I., Tseng, C.-H., et al. (2012). Quality of life predicts survival in patients with non-small cell lung cancer. BMC Public Health, 12(1), 1–1.
Ediebah, D. E., Coens, C., Zikos, E., et al. (2014). Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. British Journal of Cancer, 110(10), 2427–2433.
Damm, K., Roeske, N., & Jacob, C. (2013). Health-related quality of life questionnaires in lung cancer trials: a systematic literature review. Health Economics Review, 3(1), 1–1.
Bouazza, Y. B., Chiairi, I., El Kharbouchi, O., et al. (2017). Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review. Lung Cancer, 113, 140–151.
Fayers, P., & Bottomley, A. (2002). Quality of life research within the EORTC—the EORTC QLQ-C30. European Journal of Cancer, 38, 125–133.
Cocks, K., King, M. T., Velikova, G., et al. (2011). Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Journal of Clinical Oncology, 29(1), 89–96.
Aaronson, N. K., Ahmedzai, S., Bergman, B., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.
Nicklasson, M., & Bergman, B. (2007). Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting. Quality of Life Research, 16(6), 1019–1028.
Costa, D. S. J., Aaronson, N. K., Fayers, P. M., et al. (2014). Testing the measurement invariance of the EORTC QLQ-C30 across primary cancer sites using multi-group confirmatory factor analysis. Quality of Life Research, 24(1), 125–133.
Osoba, D., Zee, B., Pater, J., et al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Quality of Life Research, 3(5), 353–364.
Cocks, K., King, M. T., Velikova, G., et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713–1721.
Bedard, G., Zeng, L., Zhang, L., et al. (2013). Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer. Asia-Pac Journal of Clinical Oncology, 10(2), 109–117.
Maringwa, J. T., Quinten, C., King, M., et al. (2011). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 19(11), 1753–1760.
Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). EORTC QLQ-C30 Scoring Manual (3rd ed.). Brussels: European Organisation for Research and Treatment of Cancer.
Shih, C.-L., Chen, C.-H., Sheu, C.-F., Lang, H.-C., & Hsieh, C.-L. (2013). Validating and Improving the Reliability of the EORTC QLQ-C30 Using a Multidimensional Rasch Model. Value Health, 16(5), 848–854.
van der Kloot, W. A., Kobayashi, K., Yamaoka, K., et al. (2014). Summarizing the fifteen scales of the EORTC QLQ-C30 Questionnaire by five aggregate scales with two underlying dimensions: A literature review and an empirical study. Journal of psychosocial oncology, 32(4), 413–430.
Gundy, C. M., Fayers, P. M., Groenvold, M., et al. (2011). Comparing higher order models for the EORTC QLQ-C30. Quality of Life Research, 21(9), 1607–1617.
Giesinger, J. M., Kieffer, J. M., Fayers, P. M., et al. (2016). Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Journal of Clinical Epidemiology, 69, 79–88.
Vinageras, E. N., de la Torre, A., Rodríguez, M. O., et al. (2008). Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non–small-cell lung cancer. Journal of Clinical Oncology, 26(9), 1452–1458.
Rodriguez, P. C., Popa, X., Martinez, O., et al. (2016). A Phase III clinical trial of the epidermal growth factor vaccine CIMAvax-EGF as switch maintenance therapy in advanced non-small cell lung cancer patients. Clinical Cancer Research, 22(15), 3782–3790.
Hernandez, M., Ortiz, R. A., Neninger, E., et al. (2016). P2.40: CIMAvaxEGF vaccine for the treatment of real-world NSCLC patients. Journal of Thoracic Oncology, 11(10), S242.
Molenaar I. W. (1997) Nonparametric models for polytomous responses. In: W. J. van der Linden., R. K. Hambleton (Eds.), Handbook of modern item response theory (pp. 369–380). New York, NY: Springer New York.
Mokken R. J. (1997) Nonparametric models for dichotomous responses. In: W. J. van der Linden., R. K. Hambleton (Eds.), Handbook of modern item response theory (pp. 351–367). New York, NY: Springer New York.
Brown, T. A. (2006). Confirmatory factor analysis for applied research. New York: The Guilford Press.
Team RC (2013) R: a language and environment for statistical computing. https://www.R-project.org/.
Ark, L. A. V. D. (2007). Mokken Scale Analysis in R. Journal of Statistical Software. https://doi.org/10.18637/JSS.V020.I11.
Ark, L. A. V. D. (2012). New developments in Mokken scale analysis in R. Journal of Statistical Software. https://doi.org/10.18637/jss.v048.i05.
Rizopoulos, D. (2006). ltm: An RPackage for latent variable modeling and item response theory analyses. Journal of Statistical Software, 17(5), 1–25.
Rosseel, Y. (2012). lavaan: An RPackage for structural equation modeling. Journal of Statistical Software, 48(2), 1–36.
Petersen, M. A., Groenvold, M., Aaronson, N., et al. (2006). Item response theory was used to shorten EORTC QLQ-C30 scales for use in palliative care. Journal of Clinical Epidemiology, 59(1), 36–44.
Arraras, J. I., Suárez, J., Arias de la Vega, F., et al. (2011). The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients. Clinical and Translational Oncology, 13(1), 50–56.
Arraras Urdaniz, J. I., Villafranca Iturre, E., Arias de la Vega, F., et al. (2008). The EORTC quality of life questionnaire QLQ-C30 (version 3.0). Validation study for Spanish prostate cancer patients. Archivos Espanoles de Urologia, 61(8), 949–954.
Scott, N. W., Fayers, P. M., Bottomley, A., et al. (2006). Comparing translations of the EORTC QLQ-C30 using differential item functioning analyses. Quality of Life Research, 15(6), 1103–1115.
Acknowledgements
We would like to thank the EORTC for authorizing us to use the QLQ-C30 questionnaires in patients with non-small cell lung cancer.
Funding
Funding for the analyses of this study was provided by a Union for International Cancer Control (UICC) Technical Fellowship Award UICC-TF/17/545061 to Carmen Viada. Javier Ballesteros is supported by UPV/EHU research groups grant (GIU14/27).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Viada, C., Bouza, C., Fors, M. et al. Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer. Qual Life Res 29, 3441–3448 (2020). https://doi.org/10.1007/s11136-020-02584-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-020-02584-5